Experimental Biology Conference: 2020
Algomedix will be presenting scientific results at the Experimental Biology, 2020, conference which is being held from April 4-7, 2020 in San Diego, California.
Algomedix will be present on ALGX-XC20, a Novel Transient Receptor Potential Ankyrin 1 (TRPA1) Antagonist Attenuates Joint Pain and Articular Cartilage Damage in an Osteoarthritis Rat Model on April 6, 2020 from 4:45 PM – 6:00 PM, at Notable Platform Presentations in Drug Discovery and Development, San Diego Convention Center.
In addition, Algomedix will be presenting on Novel TRPA1 Antagonists are Multimodal Blockers of Human TRPA1 Channels: Drug Candidates for Treatment of Familial Episodic Pain Syndrome (FEPS) on April 7, 2020 at the San Diego Convention Center.
Biocom’s 10th Annual Global Life Science Partnering Conference : 2020
Algomedix will be attending and holding partnering meetings at Biocom’s 10th Annual Global Life Science Partnering Conference, February 25-27, 2020 in La Jolla, California.
Kyoto University Life Science Showcase: 2020
Algomedix will be participating in the Kyoto University Life Science meeting on February 28th, 2020 in La Jolla, California at the Sanford Consortium for Regenernative Medicine.
Bio-Japan/Asia’s Premier Partnering Event for Global Biotechnology Industry 2019
Algomedix has been selected to participate in the Bio-Japan 2019 meeting: Asia’s Premier Partnering Event for the Global Biotechnology Industry 2019, October 9th – 12th, 2019, Yokohama, Japan. Algomedix will join the California Biocom delegation at the meeting.
Link-J Global Life Science Session: 2019
Algomedix will present at the Link-J Global Life Science Session to be held on October 8th, 2019 at the Nihonbashi Life Science Hub, Tokyo, Japan
Precision Medicine & Ion Channel Retreat 2019
Algomedix will present at the Precision Medicine & Ion Channel Retreat 2019 meeting, July 24th-26th, 2019 in Vancouver, British Columbia, Canada. Dr. Herz will deliver a podium presentation: Targeting TRPA1 for Development of Novel Analgesics.
Biocom’s Venture Day: 2019
Algomedix will be participating in the Venture Day meeting, June 19th, 2019 in San Diego, California.
Biocom’s 9th Annual Global Life Science Partnering Conference : 2019
Algomedix will be attending and holding partnering meetings at Biocom’s Annual Global Life Science Partnering Conference, February 27-28, 2019 in La Jolla, California.
Wilson Sonsini Goodrich and Rosati (WSGR) Healthcare Investment Forum
Algomedix has been selected to participate in the 4th Wilson Sonsini Goodrich and Rosati (WSGR) Healthcare Investment Forum in Palo Alto, California which is taking place on November 7th and 8th, 2018. The WSGR Investment Forum presents an opportunity for life science venture investment firms to connect with promising start-ups to discuss potential funding.
Bio-Japan/Regenerative Medicine 2018: Partnering Conference
Algomedix will be holding partnering meetings at Bio-Japan 2018, October 10-12, 2018 in Yokohama, Japan. Dr. Herz will present a talk on October 11th in the Pacifico Yokohama Main Exhibit Hall, Stage A, at 12:05pm describing the Algomedix novel therapeutic for the treatment of chronic pain. Algomedix will also be present at booth C-01 in the Exhibit Hall together with members of Biocom, California.